Lamb Weston (LW)
(Delayed Data from NYSE)
$78.22 USD
+7.22 (10.17%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $78.22 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.22 USD
+7.22 (10.17%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $78.22 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth D Momentum A VGM
Zacks News
Capacity Expansions Aid Lamb Weston (LW), High Costs Ail
by Zacks Equity Research
Lamb Weston (LW) is focused on strategic growth efforts like expanding capacity. However, cost inflation for key inputs like raw potatoes, energy and labor is a downside.
Lamb Weston (LW) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Lamb Weston (LW) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Lamb Weston (LW) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Lamb Weston (LW) closed at $94.64 in the latest trading session, marking a -1.41% move from the prior day.
Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXG
Lamb Weston (LW) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Lamb Weston (LW) closed at $97.99, marking a -1.35% move from the previous day.
Lamb Weston (LW) Gains on Pricing Action Amid Cost Inflation
by Zacks Equity Research
Lamb Weston (LW) benefits from robust price/mix. Also, the company is focused on undertaking strategic growth efforts like expanding capacity.
Factors Likely to Influence Post Holdings' (POST) Q3 Earnings
by Zacks Equity Research
Post Holdings' (POST) Q3 results are likely to benefit from strength across the foodservice, refrigerated retail and Post consumer brands segments amid inflationary pressure and supply-chain issues.
Colgate (CL) Q2 Earnings & Sales Surpass Estimates, View Up
by Zacks Equity Research
Colgate-Palmolive's (CL) second-quarter 2023 organic sales advance 8%, with improvements in all divisions and categories.
5 Safe Stocks to Buy as Fed Resumes Interest Rate Hikes
by Ritujay Ghosh
The Fed raised interest rates again and has indicated more hikes. It would be wise to invest in stocks like Ingredion (INGR), Consolidated Water (CWCO), Lamb Weston Holdings, Inc. (LW), Entergy Corporation (ETR) and FirstEnergy (FE).
Campbell Soup (CPB) to Increase Goldfish Crackers' Production
by Zacks Equity Research
Campbell Soup (CPB) announces investment to expand the production of Goldfish crackers.
Lamb Weston (LW) Q4 Earnings & Sales Top Estimates, Rise Y/Y
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter fiscal 2023 results reflect increased earnings and sales with gains from robust pricing and supply chain productivity savings.
Lamb Weston (LW) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Lamb Weston (LW) give a sense of how its business performed in the quarter ended May 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Lamb Weston (LW) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Lamb Weston (LW) delivered earnings and revenue surprises of 16.19% and 2.49%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?
Tyson Foods (TSN) Down More Than 20% in 6 Months: Here's Why
by Zacks Equity Research
Tyson Foods (TSN) continues to operate in a challenging industry backdrop with increased costs of raw materials and labor. Weakness in the beef unit is also a concern.
Helen of Troy (HELE) Up More Than 50% in 3 Months: Here's Why
by Zacks Equity Research
Helen of Troy (HELE) is focused on developing a global restructuring plan, Project Pegasus. Investments in its Leadership Brands are yielding.
Lamb Weston (LW) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Lamb Weston (LW) closed at $113.28, marking a +0.81% move from the previous day.
Philip Morris (PM) Q2 Earnings Beat Estimates, Pricing Aids
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2023 results reflect gains from favorable pricing variance and strong smoke-free product volumes.
Mondelez (MDLZ) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Mondelez (MDLZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lamb Weston (LW) Gears Up for Q4 Earnings: What's in Store?
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter fiscal 2023 performance is likely to reflect gains from expansion efforts and effective pricing actions.
United Natural (UNFI) Stock Down More Than 45% YTD: Here's Why
by Zacks Equity Research
United Natural (UNFI) continues to operate in a challenging industry backdrop with increased cost inflation, supply-chain bottlenecks and operational complexities.
Sysco (SYY) Gains on Solid Supply Chain, Recipe for Growth
by Zacks Equity Research
Sysco (SYY) has been benefiting from its unwavering focus on growth strategies like supply-chain optimization, digital transformation and customer-centric initiatives.
Corteva (CTVA) & Bioceres to Drive Bio Solutions in Europe
by Zacks Equity Research
Corteva Agriscience (CTVA) and Bioceres Crop Solutions mark a significant milestone in the expansion of biological solutions in Europe.
Zacks Industry Outlook Highlights Lamb Weston Holdings, TreeHouse, McCormick and Celsius
by Zacks Equity Research
Lamb Weston Holdings, TreeHouse, McCormick and Celsius have been highlighted in this Industry Outlook article.
Ross Stores (ROST) Expands Footprint, Unveils 27 New Locations
by Zacks Equity Research
Ross Stores (ROST) strengthens brand visibility, captures new customers and unlocks potential sales growth by expanding its store network.
Capacity Expansions Fuel Hormel Foods (HRL), High Costs Ail
by Zacks Equity Research
Hormel Foods (HRL) intends to strengthen its business on the back of strategic acquisitions. The company is on track with stabilizing margin pressures amid cost inflation.